Clare Mary Horkan, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 4 | 2017 | 2744 | 0.360 |
Why?
|
| Catheter Ablation | 7 | 2008 | 2788 | 0.290 |
Why?
|
| Intensive Care Units | 4 | 2017 | 3800 | 0.260 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1946 | 0.200 |
Why?
|
| Patient Readmission | 2 | 2017 | 3286 | 0.190 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 1229 | 0.160 |
Why?
|
| Survivors | 3 | 2017 | 2372 | 0.150 |
Why?
|
| Rho(D) Immune Globulin | 2 | 2008 | 34 | 0.140 |
Why?
|
| Erythroblasts | 1 | 2017 | 142 | 0.140 |
Why?
|
| Venereal Tumors, Veterinary | 2 | 2006 | 8 | 0.120 |
Why?
|
| Acetic Acid | 2 | 2006 | 58 | 0.120 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 683 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 2 | 2008 | 245 | 0.100 |
Why?
|
| Malnutrition | 1 | 2017 | 629 | 0.090 |
Why?
|
| Rats, Inbred F344 | 3 | 2008 | 822 | 0.090 |
Why?
|
| Doxorubicin | 2 | 2008 | 2230 | 0.090 |
Why?
|
| Injections, Intralesional | 2 | 2006 | 281 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4353 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 4274 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2017 | 3461 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2008 | 498 | 0.060 |
Why?
|
| Sarcoma, Experimental | 1 | 2005 | 116 | 0.060 |
Why?
|
| Liver | 3 | 2005 | 7562 | 0.060 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2008 | 302 | 0.060 |
Why?
|
| Sex Factors | 2 | 2016 | 10603 | 0.060 |
Why?
|
| Age Factors | 3 | 2016 | 18380 | 0.060 |
Why?
|
| Adrenergic Agonists | 1 | 2004 | 55 | 0.060 |
Why?
|
| Halothane | 1 | 2004 | 200 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 2 | 2015 | 2495 | 0.050 |
Why?
|
| Arsenicals | 1 | 2004 | 117 | 0.050 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 236 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2511 | 0.050 |
Why?
|
| Health Status | 1 | 2016 | 4080 | 0.050 |
Why?
|
| Dog Diseases | 1 | 2003 | 142 | 0.050 |
Why?
|
| Oxides | 1 | 2004 | 402 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2002 | 87 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2008 | 8529 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 587 | 0.050 |
Why?
|
| Rabbits | 2 | 2005 | 4734 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2017 | 41649 | 0.050 |
Why?
|
| Pneumonia, Aspiration | 1 | 2001 | 145 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2017 | 9649 | 0.040 |
Why?
|
| Epinephrine | 1 | 2004 | 783 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1478 | 0.040 |
Why?
|
| Magnetics | 1 | 2003 | 585 | 0.040 |
Why?
|
| Motor Activity | 2 | 2016 | 2704 | 0.040 |
Why?
|
| Liver Failure | 1 | 2002 | 252 | 0.040 |
Why?
|
| Cryosurgery | 1 | 2004 | 479 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2001 | 392 | 0.040 |
Why?
|
| Kidney | 2 | 2005 | 7066 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2004 | 573 | 0.040 |
Why?
|
| Motor Cortex | 2 | 2003 | 1003 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2002 | 648 | 0.040 |
Why?
|
| Necrosis | 3 | 2008 | 1617 | 0.040 |
Why?
|
| Foot | 1 | 2001 | 573 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 21056 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2015 | 24282 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2017 | 95 | 0.030 |
Why?
|
| Survival Rate | 2 | 2016 | 12795 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2002 | 1167 | 0.030 |
Why?
|
| Diffusion | 3 | 2003 | 808 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2005 | 1165 | 0.030 |
Why?
|
| Aged | 9 | 2017 | 171117 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 2 | 2008 | 2648 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2004 | 1546 | 0.030 |
Why?
|
| Rats | 3 | 2008 | 23707 | 0.030 |
Why?
|
| Risk Factors | 4 | 2017 | 74840 | 0.030 |
Why?
|
| Wakefulness | 1 | 2002 | 1282 | 0.030 |
Why?
|
| Sarcoma | 1 | 2006 | 1802 | 0.030 |
Why?
|
| Female | 13 | 2017 | 396112 | 0.030 |
Why?
|
| Adult | 9 | 2017 | 223044 | 0.030 |
Why?
|
| Middle Aged | 8 | 2017 | 223009 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1909 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2002 | 2080 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2312 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 533 | 0.020 |
Why?
|
| Male | 11 | 2017 | 363698 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2005 | 6255 | 0.020 |
Why?
|
| Fatal Outcome | 2 | 2008 | 1831 | 0.020 |
Why?
|
| Gait | 1 | 2016 | 820 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2001 | 2709 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 4958 | 0.020 |
Why?
|
| Stroke | 2 | 2002 | 9747 | 0.020 |
Why?
|
| Animals | 7 | 2008 | 168764 | 0.020 |
Why?
|
| Dogs | 2 | 2006 | 3822 | 0.020 |
Why?
|
| Thermography | 1 | 2008 | 62 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 36532 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2008 | 3537 | 0.020 |
Why?
|
| Ethanol | 2 | 2006 | 1323 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2002 | 6601 | 0.020 |
Why?
|
| Humans | 14 | 2017 | 765968 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 5767 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2966 | 0.020 |
Why?
|
| Water | 2 | 2002 | 1417 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2006 | 6322 | 0.020 |
Why?
|
| Registries | 2 | 2017 | 8297 | 0.020 |
Why?
|
| Liposomes | 1 | 2008 | 788 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18293 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9338 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2005 | 403 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2005 | 165 | 0.010 |
Why?
|
| Aging | 1 | 2002 | 8731 | 0.010 |
Why?
|
| Sepsis | 1 | 2017 | 2606 | 0.010 |
Why?
|
| Critical Care | 1 | 2016 | 2712 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 59489 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 40065 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2005 | 440 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2002 | 149 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 2014 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 616 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 2002 | 387 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13648 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2266 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2005 | 1749 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 778 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 2001 | 170 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2004 | 669 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 15747 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3801 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 2002 | 510 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2004 | 1530 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15880 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 1641 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 1531 | 0.010 |
Why?
|
| Hand | 1 | 2002 | 909 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29922 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 3481 | 0.010 |
Why?
|
| Hospitalization | 1 | 2016 | 10808 | 0.010 |
Why?
|
| Thalamus | 1 | 2002 | 1048 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2002 | 1410 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2002 | 2243 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6203 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2002 | 15398 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2016 | 81514 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 1426 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65188 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 5988 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2002 | 1008 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2002 | 1799 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6364 | 0.010 |
Why?
|
| Nerve Net | 1 | 2002 | 2309 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4209 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2002 | 3000 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 12056 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12976 | 0.000 |
Why?
|
| Sleep | 1 | 2002 | 4813 | 0.000 |
Why?
|
| Brain | 1 | 2002 | 27171 | 0.000 |
Why?
|